158 related articles for article (PubMed ID: 34419617)
1. Altered gut microbiome in FUT2 loss-of-function mutants in support of personalized medicine for inflammatory bowel diseases.
Cheng S; Hu J; Wu X; Pan JA; Jiao N; Li Y; Huang Y; Lin X; Zou Y; Chen Y; Zhu L; Zhi M; Lan P
J Genet Genomics; 2021 Sep; 48(9):771-780. PubMed ID: 34419617
[TBL] [Abstract][Full Text] [Related]
2. Reprograming of gut microbiome energy metabolism by the FUT2 Crohn's disease risk polymorphism.
Tong M; McHardy I; Ruegger P; Goudarzi M; Kashyap PC; Haritunians T; Li X; Graeber TG; Schwager E; Huttenhower C; Fornace AJ; Sonnenburg JL; McGovern DP; Borneman J; Braun J
ISME J; 2014 Nov; 8(11):2193-206. PubMed ID: 24781901
[TBL] [Abstract][Full Text] [Related]
3.
Taylor SL; Woodman RJ; Chen AC; Burr LD; Gordon DL; McGuckin MA; Wesselingh S; Rogers GB
Thorax; 2017 Apr; 72(4):304-310. PubMed ID: 27503233
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota-mediated lysophosphatidylcholine generation promotes colitis in intestinal epithelium-specific Fut2 deficiency.
Tang X; Wang W; Hong G; Duan C; Zhu S; Tian Y; Han C; Qian W; Lin R; Hou X
J Biomed Sci; 2021 Mar; 28(1):20. PubMed ID: 33722220
[TBL] [Abstract][Full Text] [Related]
5. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
[TBL] [Abstract][Full Text] [Related]
6. Gut Microbiome Composition and Metabolic Capacity Differ by
Thorman AW; Adkins G; Conrey SC; Burrell AR; Yu Y; White B; Burke R; Haslam D; Payne DC; Staat MA; Morrow AL; Newburg DS
Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678342
[TBL] [Abstract][Full Text] [Related]
7. Fucosyltransferase 2: A Genetic Risk Factor for Intestinal Diseases.
Hu M; Zhang X; Li J; Chen L; He X; Sui T
Front Microbiol; 2022; 13():940196. PubMed ID: 35923409
[TBL] [Abstract][Full Text] [Related]
8. Association study of FUT2 (rs601338) with celiac disease and inflammatory bowel disease in the Finnish population.
Parmar AS; Alakulppi N; Paavola-Sakki P; Kurppa K; Halme L; Färkkilä M; Turunen U; Lappalainen M; Kontula K; Kaukinen K; Mäki M; Lindfors K; Partanen J; Sistonen P; Mättö J; Wacklin P; Saavalainen P; Einarsdottir E
Tissue Antigens; 2012 Dec; 80(6):488-93. PubMed ID: 23075394
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
Aden K; Rehman A; Waschina S; Pan WH; Walker A; Lucio M; Nunez AM; Bharti R; Zimmerman J; Bethge J; Schulte B; Schulte D; Franke A; Nikolaus S; Schroeder JO; Vandeputte D; Raes J; Szymczak S; Waetzig GH; Zeuner R; Schmitt-Kopplin P; Kaleta C; Schreiber S; Rosenstiel P
Gastroenterology; 2019 Nov; 157(5):1279-1292.e11. PubMed ID: 31326413
[TBL] [Abstract][Full Text] [Related]
10. Association of Fucosyltransferase 2 Gene Polymorphisms with Inflammatory Bowel Disease in Patients from Southeast China.
Wu H; Sun L; Lin DP; Shao XX; Xia SL; Lv M
Gastroenterol Res Pract; 2017; 2017():4148651. PubMed ID: 28167958
[No Abstract] [Full Text] [Related]
11. Antimicrobial peptides and the gut microbiome in inflammatory bowel disease.
Gubatan J; Holman DR; Puntasecca CJ; Polevoi D; Rubin SJ; Rogalla S
World J Gastroenterol; 2021 Nov; 27(43):7402-7422. PubMed ID: 34887639
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota in the pathogenesis of inflammatory bowel disease.
Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
[TBL] [Abstract][Full Text] [Related]
13. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome.
Schirmer M; Franzosa EA; Lloyd-Price J; McIver LJ; Schwager R; Poon TW; Ananthakrishnan AN; Andrews E; Barron G; Lake K; Prasad M; Sauk J; Stevens B; Wilson RG; Braun J; Denson LA; Kugathasan S; McGovern DPB; Vlamakis H; Xavier RJ; Huttenhower C
Nat Microbiol; 2018 Mar; 3(3):337-346. PubMed ID: 29311644
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids and microbiota regulate ontogeny of intestinal fucosyltransferase 2 requisite for gut homeostasis.
Nanthakumar NN; Meng D; Newburg DS
Glycobiology; 2013 Oct; 23(10):1131-41. PubMed ID: 23887940
[TBL] [Abstract][Full Text] [Related]
16. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside, a major bioactive component from Polygoni multiflori Radix (Heshouwu) suppresses DSS induced acute colitis in BALb/c mice by modulating gut microbiota.
He X; Liu J; Long G; Xia XH; Liu M
Biomed Pharmacother; 2021 May; 137():111420. PubMed ID: 33761623
[TBL] [Abstract][Full Text] [Related]
17. Fucosylated Human Milk Oligosaccharides and N-Glycans in the Milk of Chinese Mothers Regulate the Gut Microbiome of Their Breast-Fed Infants during Different Lactation Stages.
Bai Y; Tao J; Zhou J; Fan Q; Liu M; Hu Y; Xu Y; Zhang L; Yuan J; Li W; Ze X; Malard P; Guo Z; Yan J; Li M
mSystems; 2018; 3(6):. PubMed ID: 30637338
[TBL] [Abstract][Full Text] [Related]
18. Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome.
Bolte LA; Vich Vila A; Imhann F; Collij V; Gacesa R; Peters V; Wijmenga C; Kurilshikov A; Campmans-Kuijpers MJE; Fu J; Dijkstra G; Zhernakova A; Weersma RK
Gut; 2021 Jul; 70(7):1287-1298. PubMed ID: 33811041
[TBL] [Abstract][Full Text] [Related]
19. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.
Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N
Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980
[TBL] [Abstract][Full Text] [Related]
20. The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review.
Aldars-García L; Marin AC; Chaparro M; Gisbert JP
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
